Nadezhda S. Samoylenkova
Moscow, MOW 125047, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Aptamers Structure Flexibility Is Crucial to EGFR Inhibition Function.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 17, 2026
Killing Glioblastoma Cells with Glycosylated Indolocarbazole-Based Derivative LCS1269: A Potential Crosstalk Between Micronuclei Formation and the Concurrent Induction of Apoptosis, Necroptosis, and Pyroptosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 02, 2026
The Aptamer bi-(AID-1-T) Synergizes with Radiation to Inhibit Proliferation of Human Glioma Cells.
Journal: Pharmaceutics
Published: October 03, 2025
Real-Time Kinetics of Internalization of Anti-EGFR DNA Aptamers and Aptamer Constructs into Cells Derived from Glioblastoma Patients as Indicated by Doxorubicin.
Journal: International journal of molecular sciences
Published: July 21, 2025
Enhancing the therapeutic effect on tumor cells through wireless optoelectronic stimulation.
Journal: Journal of neuro-oncology
Published: May 12, 2025
Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation.
Journal: International journal of molecular sciences
Published: April 21, 2025
Enhancing Survival Prediction: The Potential of Whole-Brain Radiomics in Multimodal Neuroimaging.
Journal: Studies in health technology and informatics
Published: April 09, 2025
N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 06, 2024
Towards Aptamer-Targeted Drug Delivery to Brain Tumors: The Synthesis of Ramified Conjugates of an EGFR-Specific Aptamer with MMAE on a Cathepsin B-Cleavable Linker.
Journal: Pharmaceutics
Published: September 19, 2024
Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells
Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
Published: February 09, 2024
Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression
Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
Published: December 06, 2023
A Combined Effect of G-Quadruplex and Neuro-Inducers as an Alternative Approach to Human Glioblastoma Therapy.
Journal: Frontiers in oncology
Published: February 21, 2022
Last Updated: 09/26/2026